BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.7B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$860M |
| 3 |
Apple
AAPL
|
+$839M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$830M |
| 5 |
GE Aerospace
GE
|
+$800M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$362M |
| 2 |
Tesla
TSLA
|
+$288M |
| 3 |
NVIDIA
NVDA
|
+$265M |
| 4 |
MetLife
MET
|
+$261M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Consumer Discretionary | 8.14% |
| 3 | Financials | 7.71% |
| 4 | Healthcare | 6.1% |
| 5 | Communication Services | 5.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LENZ
4251
LENZ Therapeutics
LENZ
$145M
| $51.6K | ﹤0.01% |
1,789
-859
| -32% | -$26.2K |
|
|
SEPN
4252
Septerna Inc
SEPN
$2.11B
| $51.5K | ﹤0.01% |
+2,251
| New | +$53.2K |
|
4253
Ribbon Communications
RBBN
$377M
| $51.5K | ﹤0.01% |
12,383
-7,009
| -36% | -$26.5K |
|
|
MESO
4254
Mesoblast
MESO
$2.14B
| $51.5K | ﹤0.01% |
2,600
+2,597
| +86,567% | +$28.8K |
|
|
LGF.B
4255
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $51.4K | ﹤0.01% |
6,806
-947
| -12% | -$6.64K |
|
4256
Quantum-Si Incorporated
QSI
$172M
| $51.4K | ﹤0.01% |
+19,025
| New | +$22.3K |
|
4257
UroGen Pharma
URGN
$2.34B
| $51.1K | ﹤0.01% |
4,801
-3,745
| -44% | -$44.8K |
|
4258
IAMGOLD
IAG
$10.1B
| $51.1K | ﹤0.01% |
9,899
-1,511,771
| -99% | -$8.08M |
|
4259
Distribution Solutions Group
DSGR
$1.61B
| $51K | ﹤0.01% |
1,482
-3,532
| -70% | -$136K |
|
|
RSVR
4260
Reservoir Media
RSVR
$656M
| $50.9K | ﹤0.01% |
+5,625
| New | +$49.6K |
|
4261
Vanguard Communication Services ETF
VOX
$5.88B
| $50.7K | ﹤0.01% |
327
+317
| +3,170% | +$48.4K |
|
|
LYRA
4262
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $50.6K | ﹤0.01% |
+4,898
| New | +$53.9K |
|
4263
Inseego
INSG
$77.7M
| $50.5K | ﹤0.01% |
4,924
+3,549
| +258% | +$52.1K |
|
4264
Primis Financial Corp
FRST
$413M
| $50.5K | ﹤0.01% |
+4,332
| New | +$52K |
|
|
GRAL
4265
GRAIL Inc
GRAL
$3.05B
| $50.3K | ﹤0.01% |
2,820
-26,214
| -90% | -$426K |
|
4266
Invesco Mortgage Capital
IVR
$805M
| $50.2K | ﹤0.01% |
+6,234
| New | +$52.3K |
|
4267
InflaRx
IFRX
$296M
| $50.1K | ﹤0.01% |
20,300
-3,000
| -13% | -$5.77K |
|
4268
Aura Biosciences
AURA
$791M
| $50.1K | ﹤0.01% |
+6,094
| New | +$57.4K |
|
|
VERV
4269
DELISTED
Verve Therapeutics
VERV
| $50.1K | ﹤0.01% |
+8,876
| New | +$50.1K |
|
4270
Tejon Ranch
TRC
$443M
| $50K | ﹤0.01% |
3,145
-1,270
| -29% | -$20.5K |
|
4271
Capricor Therapeutics
CAPR
$244M
| $50K | ﹤0.01% |
3,622
-14,077
| -80% | -$247K |
|
4272
Clean Energy Fuels
CLNE
$395M
| $49.8K | ﹤0.01% |
19,848
-17,376
| -47% | -$49.3K |
|
|
ATXS
4273
DELISTED
Astria Therapeutics
ATXS
| $49.8K | ﹤0.01% |
+5,572
| New | +$59.2K |
|
4274
Kodiak Sciences
KOD
$2.5B
| $49.8K | ﹤0.01% |
5,004
-1,562
| -24% | -$8.98K |
|
|
SKYT
4275
DELISTED
SkyWater Technology
SKYT
| $49.7K | ﹤0.01% |
+3,598
| New | +$35.7K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2024 Portfolio in Review
As of Q4 2024, BNP Paribas Financial Markets held 5,601 positions worth $178B, up 20% from $149B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets deployed $23.8B of net new capital in Q4 2024, opening 1,444 new positions and adding to 1,732 existing holdings. Its largest new stake was GE Aerospace: 4,486,125 shares worth $748M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Utilities Select Sector SPDR ETF, an estimated $362M trimmed.
- BNP Paribas Financial Markets's largest Q4 2024 buy was GE Aerospace: 4,486,125 shares worth $748M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $1.7B increase.
- BNP Paribas Financial Markets's biggest Q4 2024 reduction was State Street Utilities Select Sector SPDR ETF, cutting an estimated $362M.
- BNP Paribas Financial Markets fully exited State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q4 2024, selling an estimated $34M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $178B portfolio in Q4 2024.
- BNP Paribas Financial Markets opened 1,444 new positions and closed 206 in Q4 2024.
- BNP Paribas Financial Markets's portfolio value rose 20% quarter-over-quarter to $178B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2024, filed 14 Feb 2025.